Home » Topics » Regulatory

Regulatory
RSS

Ragwitek sublingual immunotherapy approved by FDA for hay fever

April 22, 2014

Lilly's VEGF-inhibiting monoclonal antibody approved for gastric cancer

April 22, 2014

Dyax receives FDA approval to expand the use of Kalbitor

April 7, 2014

Subcutaneous MabThera approved in Europe for two forms of NHL

March 31, 2014

Albiglutide approved in Europe for type 2 diabetes

March 27, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Tofogliflozin hydrate approved for type 2 diabetes in Japan

March 26, 2014

Kaketsuken announces Japanese approval of cell culture pandemic influenza vaccine

March 26, 2014

Japanese approval of Lusefi for type 2 diabetes

March 25, 2014

Takelda combination tablets approved in Japan

March 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...